BioFlorida is the voice of Florida’s bioscience industry representing more than 3,000 companies and research organizations in the biotechnology, pharmaceutical and medical device fields employing 61,000 Floridians. BioFlorida’s member-driven initiatives provide a strong business climate for production of quality, life-improving technologies and promote economic benefits to the state.
As the statewide trade association for the bioscience industry, BioFlorida provides companies with the necessary resources to succeed, and a strong marketing presence both locally and internationally.
BioFlorida serves its membership by providing a network to exchange information and discuss issues related to the field. Regional and statewide industry-specific programs, educational forums, as well as a variety of networking opportunities address important and timely issues such as:
- Biotech & Pharmaceutical
- Business Development & Partnering
- CEO Best Practices
- Corporate Finance
- Education & Workforce Development
- Emerging Leaders
- Licensing Issues
- Medical Device R&D and/or Manufacturing
- Real Estate & Development
- Research & Commercialization
525 Okeechobee Blvd., Suite 1500, West Palm Beach, FL 33401
Company Profile online shortly
BIOMINAS BRASIL – Your ideal partner to succeed in life sciences in Latin America
Biominas Brasil is a private institution dedicated to growing businesses and promoting business opportunities in Brazil’s life sciences sector. Since it started operating in 1990, it has been instrumental in the establishment of many companies in the industry. From conception to maturity, we help businesses develop by providing:
• Specialized consultancy • Business development expertise
• Business incubation • Investments
Biominas Brasil has at its disposal the wide range of expertise and contacts needed to drive the creation and development of successful business enterprises in the life sciences.
The first entity in Brazil to provide specialized programs and services for the area, we have become a national reference in the life sciences business for the significant contributions we have made to the growth of this market in the country.
For further information: www.biominas.org.br
Katan Associates is a corporate strategy and finance advisory group focused on the global life sciences industry. Our mission is to add and create value for therapeutic and technology-based companies by implementing operational improvements and corporate capitalization strategies that will benefit your shareholders.
Katan is driven to consistently deliver results by leveraging our experience and industry and investor relationships to benefit our clients. Working closely with a handful of carefully selected clients, Katan Associates will identify and analyze your strategic opportunities, transactional requirements, operational needs and provide industry perspective essential to creating long-term shareholder value.
Our primary focus is on the development of novel therapeutics and platforms. We enhance the therapeutic focus with investments in medical devices, diagnostics or drug delivery systems. In our investments we look for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program.
We prefer to have our initial investment at the early stage to build the company and follow with additional investment in pace with the company’s progress. We continue our approach of larger focused investments and anticipate total investments up to USD 15 – 20 mio per company over its life, but it can be as little as 100'000 USD to get started.
We will increase our activities to lead or co-lead deals further and remain open to participate in larger syndicates.
• New therapeutics & platforms
• Medical devices/implants
• Drug delivery/biopolymers
Royal DSM N.V. is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials.
DSM’s 22,000 employees deliver annual net sales of about €9 billion. The company is listed on NYSE Euronext.
At Inovio, we are seeking to help patients by improving their quality of life through innovative research. Our vision is to address cancers and chronic infectious diseases with a new generation of safe and effective vaccines for preventive and therapeutic purposes.
DNA-based vaccines potentially represent a multi-billion-dollar business opportunity.
We believe that Inovio's strong intellectual property and proprietary technology relating to electroporation-based DNA vaccines enables us to play a leadership role in advancing the development and potential commercialization of this important new generation of immunotherapies.
Torreya Partners LLC is a leading boutique advisory firm that provides strategic advice and assistance with Mergers & Acquisitions, Partnering and Financings to life science companies worldwide. Torreya Partners provides the long-term thinking and objective advice required for life science companies to create lasting value. We take great pride in handling complex financial and strategic matters for some of the most sophisticated private and public life science companies in the world. Our reputation has been built on quality advice, excellence in deal execution and good outcomes for our clients. We bring the caliber of people and quality of relationships found in some of the largest investment banks along with the attentive, detailed service you expect from a boutique advisory firm. Torreya Partners has offices located in New York, Philadelphia and San Francisco.